AnalystsMichael RyskinMichael Ryskin's Stock Forecasts
AnalystsMichael Ryskin
Analyst Ranking
Bottom 12%
#4027 out of 4554 analysts
Average Return
-4.57%
Win Rate
43%9 out of 21
Risk vs Reward
Poor
Good
Michael Ryskin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Singular Genomics Systems IncOMIC | +79.62% | $3.44 | $0.70 | 2022-08-09 - 2023-08-09 | Sell |
Absci CorpABSI | +75.41% | $12.89 | $3.17 | 2021-11-09 - 2022-11-09 | Sell |
Maravai Lifesciences Holdings IncMRVI | +36.14% | $5.59 | $7.61 | 2023-12-11 - 2024-04-18 | Strong Buy |
Align Technology IncALGN | +31.83% | $503.31 | $343.10 | 2022-02-02 - 2023-02-03 | Sell |
Zoetis IncZTS | +29.58% | $145.15 | $188.09 | 2021-03-07 - 2022-03-07 | Strong Buy |
Michael Ryskin Analyst Color
Get additional color on Michael Ryskin's coverage of popular stocks
Michael Ryskin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exscientia PLCEXAI | 2 | Hold | $9.00 | +106.42% | Downgrades | 3 months ago |
Maravai Lifesciences Holdings IncMRVI | 2 | Strong Buy | $8.00 | +5.12% | Upgrades | 4 months ago |
Certara IncCERT | 2 | Strong Buy | $24.00 | +48.06% | Maintains | 8 months ago |
Avantor IncAVTR | 2 | Strong Buy | $24.00 | -1.23% | Maintains | 9 months ago |
Abcam PLCABCM | 2 | Strong Buy | $25.00 | +4.21% | Upgrades | 10 months ago |
Align Technology IncALGN | 5 | Sell | $225.00 | -25.33% | Maintains | a year ago |
Zoetis IncZTS | 6 | Strong Buy | $180.00 | N/A | Maintains | a year ago |
Singular Genomics Systems IncOMIC | 3 | Sell | $3.00 | N/A | Downgrades | 2 years ago |
Idexx Laboratories IncIDXX | 1 | Hold | $470.00 | N/A | Downgrades | 2 years ago |
Recursion Pharmaceuticals IncRXRX | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Schrodinger IncSDGR | 2 | Hold | $52.00 | N/A | Downgrades | 2 years ago |
Absci CorpABSI | 2 | Sell | $10.00 | N/A | Downgrades | 2 years ago |
Smiledirectclub IncSDCCQ | 1 | Sell | $7.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.